Anixa Biosciences Inc (ANIX)

Currency in USD
3.270
+0.130(+4.14%)
Closed·
3.330+0.060(+1.83%)
·
Advertisement
Unusual trading volume
ANIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.1513.484
52 wk Range
2.3205.457
Key Statistics
Prev. Close
3.14
Open
3.2
Day's Range
3.151-3.484
52 wk Range
2.32-5.457
Volume
595.41K
Average Volume (3m)
169.77K
1-Year Change
1.2384%
Book Value / Share
0.43
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANIX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.000
Upside
+205.81%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Anixa Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.000
(+205.81% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy7.00+114.07%-Maintain12/06/2026
H.C. Wainwright
Buy7.00+114.07%-Maintain11/09/2025
H.C. Wainwright
Buy7.00+114.07%-Maintain25/07/2025

Earnings

Latest Release
05/06/2026
EPS / Forecast
-0.07 / -0.08
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare ANIX to Peers and Sector

Metrics to compare
ANIX
Peers
Sector
Relationship
P/E Ratio
−11.1x−3.1x−0.4x
PEG Ratio
−0.57−0.010.00
Price/Book
7.7x2.6x2.6x
Price / LTM Sales
-9.0x3.0x
Upside (Analyst Target)
190.5%164.5%49.1%
Fair Value Upside
Unlock−4.3%6.1%Unlock

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.94M5.70%6.34M
Other Institutional Investors
3.20M9.39%10.45M
Public Companies & Retail Investors
28.89M84.91%94.47M
Total
34.02M100.00%111.26M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard Capital Management, LLC3.86%1,314,9824,300
Vanguard Index Funds - Vanguard Total Stock Market ETF2.75%936,9273,064

People Also Watch

0.9555
ONCO
-11.53%
10.4100
AKTX
+1.56%
0.452
EONR
-3.83%
2.65
CRMT
-5.02%
1.0700
LUCD
+1.90%

FAQ

What Is the Anixa Biosciences (NASDAQ: ANIX) Share Price Today?

The Anixa Biosciences stock price today is 3.270 USD.

What Stock Exchange Does Anixa Biosciences (ANIX) Trade On?

Anixa Biosciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Anixa Biosciences?

The stock symbol (also called a 'ticker') for Anixa Biosciences is "ANIX."

What Is the Current Anixa Biosciences Market Capitalisation?

As of today, Anixa Biosciences (NASDAQ: ANIX) market cap is 111.260M USD.

What Is Anixa Biosciences's (ANIX) Earnings Per Share (TTM)?

The Anixa Biosciences EPS is currently -0.304 (Trailing Twelve Months).

When Is the Next Anixa Biosciences Earnings Date?

Anixa Biosciences's next earnings report will be released on 11/09/2026.

Is ANIX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Anixa Biosciences moving averages and other technical indicators, the daily buy/sell signal for ANIX stock is Strong Buy.

How Many Times Has Anixa Biosciences Stock Split?

Anixa Biosciences has split 5 times. (See the ANIX stock split history page for full effective split date and price information.)

How Many Employees Does Anixa Biosciences Have?

Anixa Biosciences has 4 employees, based on their latest Companies House report.

What is the current trading status of Anixa Biosciences (NASDAQ: ANIX)?

As of 04/07/2026, Anixa Biosciences (ANIX) is trading at a share price of 3.270 USD, with a previous close of 3.140 USD. The stock has fluctuated within a day range of 3.151 USD to 3.484 USD, while its 52-week range spans from 2.320 USD to 5.457 USD.

What Is Anixa Biosciences (ANIX) Price Target According to Analysts?

The average 12-month price target for Anixa Biosciences is 10.000 USD, with a high estimate of 14 USD and a low estimate of 7 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +205.81% Upside potential.

What Is the ANIX After Hours Price?

ANIX's last after hours stock price is 3.330 USD, the stock has decreased by 0.060, or 1.830%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.